Amgen Selects Sofia, BioWisdom's Intelligence Solution for the Healthcare Industry

CAMBRIDGE, UNITED KINGDOM--(Marketwire - February 28, 2008) - BioWisdom Limited (BioWisdom), a leader in the provision of healthcare software and healthcare intelligence for the pharmaceutical industry, today announced that Amgen, Inc. (NASDAQ: AMGN) has signed a multi-year deal for its Sofia™ product to assist in business critical decision-making.

Back to news